Global Artificial Heart Lung Market by Application, by Type, by Region and Segment, Forecasts 2020–2026

Global Artificial Heart Lung Market was valued at USD 280.2 Million in 2018, and is expected to grow at CAGR of 6.25% over the forecast period 2020–2026. Increase in prevalence of cardiovascular diseases and instances of organ failures coupled with growing requirement and popularity of artificial hearts owing to their effective results are the key factors driving the market.

Get Sample Report:https://dataintelo.com/request-sample/?reportId=130040

Rise in the prevalence of heart diseases, awareness about cardiovascular devices, and growth in geriatric population are expected to drive the market growth. In addition, technological advancements and improvement in healthcare facilities will fuel the market growth. However, factors such as stringent government regulations and dearth of skilled professionals are expected to restrain the market growth. Increase in government investments in the healthcare sector is expected to offer new opportunities during the analysis period.

The artificial heart-lung market is segmented based on type, application, and geography. Based on type the market is segmented into single roller pump, and double roller pump. By application, the market is classified into cardiac surgery, lung transplantation operations, acute respiratory failure treatment, and others. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Market Trends, Drivers, Restraints and Opportunity:

Rise in demand for cardiovascular devices followed by rise in geriatric population is anticipated to influence the market growth in the following years. Technological advances in the medical industry is expected to propel the market growth in the years to come
Government investments in the healthcare industry is expected to play a pivotal role in the development of artificial heart lung market
Medical cases with respiratory disorders and cancers in developed countries is expected to rise in the following years thus triggering the need for artificial heart lung treatment
On contrary, low awareness and significant costs associated with the treatment creates a restriction on market dynamics